BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2
25500 results:

  • 1. Metastatic Merkel Cell Carcinoma After Simultaneous Pancreas-kidney Transplantation: Fatal Outcomes.
    Burke O; Labib A; Burke G; Beer J; Nichols A
    J Drugs Dermatol; 2024 May; 23(5):376-379. PubMed ID: 38709686
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evolving horizons in renal angiomyolipoma: two decades of management strategies and clinical perspectives in a single institutional study.
    Keles A; Iplikci A; Arikan O; Culpan M; Baydili KN; Keser F; Yildirim A
    Aging Male; 2024 Dec; 27(1):2346308. PubMed ID: 38709235
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
    Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.
    Wei G; Zhao Y; Feng S; Yuan J; Xu G; Lv T; Yang J; Kong L; Yang J
    BMC Cancer; 2024 May; 24(1):558. PubMed ID: 38702621
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparison of the perioperative outcomes of robot-assisted laparoscopic transperitoneal versus retraperitoneal partial nephrectomy for posterior-lateral renal tumors: a systematic review and meta-analysis.
    Xu P; Luo J; Shuai H; Cai T; Cui S; Zhou L; Xu Q; Zhao Y; Chen T; Shan W; Wu T
    J Robot Surg; 2024 Apr; 18(1):186. PubMed ID: 38683492
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor.
    Guo Y; Lu W; Zhang Z; Liu H; Zhang A; Zhang T; Wu Y; Li X; Yang S; Cui Q; Li Z
    BMC Pediatr; 2024 Apr; 24(1):279. PubMed ID: 38678251
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
    Scilipoti P; Rosiello G; Larcher A; Fallara G; Cignoli D; Re C; Musso G; Cei F; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
    World J Urol; 2024 Apr; 42(1):264. PubMed ID: 38676733
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Machine Learning Gene Signature to Metastatic ccRCC Based on ceRNA Network.
    Farias E; Terrematte P; Stransky B
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673800
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Modern view on the problem of diagnostics of renal angiomioadenomatous tumor].
    Osmanov Y I; Kogan E A; Gadzhieva Z K; Radenska-Lopovok S G; Prochenko D D
    Urologiia; 2024 Mar; (1):92-95. PubMed ID: 38650412
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial.
    Björnebo L; Discacciati A; Falagario U; Vigneswaran HT; Jäderling F; Grönberg H; Eklund M; Nordström T; Lantz A
    JAMA Netw Open; 2024 Apr; 7(4):e247131. PubMed ID: 38648061
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
    Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
    Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma.
    Xu J; Zhang W; Tong J; Liu C; Zhang Q; Cao L; Yu J; Zhou A; Ma J
    Cancer Immunol Immunother; 2024 Apr; 73(6):107. PubMed ID: 38642109
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
    Choueiri TK; Tomczak P; Park SH; Venugopal B; Ferguson T; Symeonides SN; Hajek J; Chang YH; Lee JL; Sarwar N; Haas NB; Gurney H; Sawrycki P; Mahave M; Gross-Goupil M; Zhang T; Burke JM; Doshi G; Melichar B; Kopyltsov E; Alva A; Oudard S; Topart D; Hammers H; Kitamura H; McDermott DF; Silva A; Winquist E; Cornell J; Elfiky A; Burgents JE; Perini RF; Powles T;
    N Engl J Med; 2024 Apr; 390(15):1359-1371. PubMed ID: 38631003
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identifying predictors of COVID-related delays in cancer-specific medical care.
    Greteman BB; Del Vecchio NJ; Garcia-Auguste CJ; Kahl AR; Gryzlak BM; Chrischilles EA; Charlton ME; Nash SH
    Cancer Med; 2024 Apr; 13(8):e7183. PubMed ID: 38629238
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-term outcome of pediatric renal transplantation with donors younger than 6 years.
    Ramirez-Amoros C; San Basilio M; Amesty V; Rivas S; Lobato R; Fernandez-Camblor C; Lopez-Pereira P; Martinez-Urrutia MJ
    Pediatr Transplant; 2024 May; 28(3):e14761. PubMed ID: 38628086
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease.
    Li H; Huntington S; Gross C; Wang SY
    PLoS One; 2024; 19(4):e0300789. PubMed ID: 38625861
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ablation of kidney tumors in Patients with Substantial kidney Impairment: Current Status.
    Iguchi T; Matsui Y; Tomita K; Uka M; Umakoshi N; Kawabata T; Gobara H; Araki M; Hiraki T
    Curr Oncol Rep; 2024 May; 26(5):573-582. PubMed ID: 38625653
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study.
    Nielson KJ; Rowsey R; Dasari S; Sukov WR; Kipp BR; Raghunathan A; Whaley RD; Ebare K; Stanton ML; Reynolds JP; Sharma V; Thompson RH; Boorjian SA; Leibovich BC; Hernandez LH; Jimenez RE; Cheville JC; Gupta S
    Hum Pathol; 2024 Apr; 146():57-65. PubMed ID: 38615998
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma.
    Wang J; He X; Mi Y; Chen YQ; Li J; Wang R
    BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multiple and hereditary renal tumors: a review for radiologists.
    Corral de la Calle MÁ; Encinas de la Iglesia J; Fernández Pérez GC; Fraino A; Repollés Cobaleda M
    Radiologia (Engl Ed); 2024; 66(2):132-154. PubMed ID: 38614530
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1275.